Cry1Ac Protoxin Confers Antitumor Adjuvant Effect in a Triple-Negative Breast Cancer Mouse Model by Improving Tumor Immunity

The Cry1Ac protoxin from Bacillus thuringiensis is a systemic and mucosal adjuvant, able to confer protective immunity in different infection murine models and induce both Th1 and TCD8+ cytotoxic lymphocyte responses, which are required to induce antitumor immunity. The Cry1Ac toxin, despite having...

Descripción completa

Detalles Bibliográficos
Autores principales: Servin-Garrido, Roberto Raúl, Ilhuicatzi-Alvarado, Damaris, Jiménez-Chávez, Ángel de Jesús, Moreno-Fierros, Leticia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738886/
https://www.ncbi.nlm.nih.gov/pubmed/35002244
http://dx.doi.org/10.1177/11782234211065154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738886/
https://www.ncbi.nlm.nih.gov/pubmed/35002244
http://dx.doi.org/10.1177/11782234211065154

Ejemplares similares